Childhood obesity redefined: fewer children classified, experts are divided

What just happened

A global redefinition of clinical obesity — applied in a Murdoch Children’s Research Institute study of 786,557 participants — has produced a number that sounds simple but carries a complex clinical undertow: childhood obesity is less common under the new definition.

The new framework, which has backing from major international obesity bodies, moves beyond body mass index as the sole diagnostic criterion. Under it, a child is only classified as clinically obese if excess body fat is accompanied by evidence of organ dysfunction — elevated blood pressure, dyslipidaemia, impaired glucose tolerance — or limitations in daily activities. Children with high BMI but no current health impairment fall instead into a pre-clinical obesity category.

Applied to the study’s global dataset including Australian children, the difference is stark: BMI criteria classified 7–10.8% of children and adolescents as obese. The clinical definition reduces that to 2.1–4.9%. Australian GPs are watching what happens next to intervention availability.

Both-and

The case for a more precise definition

BMI has always been a blunt instrument — particularly in childhood, where body composition changes rapidly and where BMI percentile thresholds carry their own uncertainties. The strongest criticism of BMI-only obesity classification in children has been that it generated diagnoses that drove stigma and sometimes inappropriate intervention without reliably predicting which children would go on to develop metabolic disease.

The new definition is clinically targeted: it identifies children who already have measurable health impairment from excess body fat, and reserves the clinical obesity label for that group. Dr Mark Mellor, a GP with an interest in metabolic health, says GPs should use the framework to move toward individualised assessment — matching intervention intensity to clinical need rather than to a number on a chart.

For adults, the finding is particularly notable in midlife and beyond: clinical obesity — as opposed to BMI-defined obesity — was actually more prevalent than BMI criteria predict in adults aged 55 and over, peaking at 52% of the 65–74 age group. The new framework catches metabolic burden that BMI misses in older adults.

The concern about reduced urgency for early intervention

The counterpoint comes from within general practice. Dr Terri-Lynne South, Chair of RACGP Specific Interests Obesity, has raised a concern with direct clinical implications: pre-clinical obesity is not no-risk obesity. A child with elevated BMI and no current organ dysfunction still faces meaningful long-term risk of cardiovascular disease, type 2 diabetes, and related conditions. Early lifestyle-focused, family-based intervention at the pre-clinical stage can change that trajectory.

The concern is not with the definition itself — it is with how a narrower definition may translate into service access and referral urgency. If fewer children are classified as clinically obese, some intervention services may deprioritise them. The definition change and the system’s response to it are not the same thing, but they interact.

Dr Danielle Longmore, the study’s lead author, notes that the distinction is likely to affect decisions about weight-loss medications and dietary recommendations — appropriate reductions in inappropriate intervention, in her view. The RACGP perspective is that this recalibration is welcome provided it does not reduce early support for children in the pre-clinical range.

What stays the same

Neither expert position argues for watchful waiting in children with high BMI. The clinical obesity definition identifies who needs intensive prioritised intervention now. Pre-clinical obesity still warrants monitoring, lifestyle support, and regular GP review — just not necessarily the same intensity of clinical management as established disease.

My two cents

The recalibration is clinically sound. A diagnosis should mean current health impairment, not just an elevated number — and the move away from BMI as the sole diagnostic criterion is a meaningful improvement on a metric that has always done imprecise work in children.

But definition changes travel faster than systems changes. The risk is that “fewer children are classified as obese” becomes “fewer children qualify for support,” which the evidence does not support. Pre-clinical obesity in a child with a strong family history of type 2 diabetes is not a reason to defer conversation and lifestyle support — it is exactly the reason to have it early.

If your child has a high BMI and you are wondering what the new definition means for them, a conversation with your GP about their current metabolic markers — not just their BMI — is the right starting point.

Verdict: maybe — a more precise clinical definition is a genuine improvement, but how it translates into service access and clinical urgency is unresolved and worth watching.

---

Sources cited

1. Childhood obesity less common under new definition. newsGP, 9 October 2026. https://www1.racgp.org.au/newsgp/clinical/childhood-obesity-less-common-under-new-definition